Biotech | December 11, 2021
Alembic acquires stake in RIGlmmune
The company is focused on the development of novel treatments for RNA viruses
The company is focused on the development of novel treatments for RNA viruses
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
Sputnik M is a new member of the Sputnik vaccines family
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19
Subscribe To Our Newsletter & Stay Updated
